PRESS RELEASE published on 05/13/2025 at 07:45, 11 months 25 days ago Eckert & Ziegler Starts with Earnings Growth in Q1 2025 and Confirms Full-Year Forecast Eckert & Ziegler SE reports earnings growth in Q1 2025 with sales of €68.2 million and net income of €9.7 million. Full-year forecast for 2025 confirmed at around €320 million in sales and €78 million in EBIT EBIT Forecast Earnings Growth Sales Forecast Eckert & Ziegler SE Q1 2025
BRIEF published on 04/24/2025 at 14:05, 1 year ago Eckert & Ziegler Signs Manufacturing Agreement with Pentixapharm Clinical Trials Cancer Therapy Manufacturing Agreement Radiopharmaceuticals Y90-PentixaTher
BRIEF published on 04/24/2025 at 14:05, 1 year ago Eckert & Ziegler signe un accord de fabrication avec Pentixapharm Essais Cliniques Accord De Fabrication Produits Radiopharmaceutiques Thérapie Contre Le Cancer Y90-PentixaTher
PRESS RELEASE published on 04/24/2025 at 14:00, 1 year ago Eckert & Ziegler Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Pentixapharm Eckert & Ziegler SE signs manufacturing agreement with Pentixapharm for Y90-PentixaTher, a targeted radiolabeled peptide therapeutic for cancer treatment Manufacturing Agreement Eckert & Ziegler SE Radiopharmaceuticals Pentixapharm Y90-PentixaTher
BRIEF published on 04/11/2025 at 10:35, 1 year ago Eckert & Ziegler propose un dividende de 0,50 € pour l'exercice 2024 Eckert & Ziegler Dividende Assemblée Générale Annuelle TecDax Exercice Financier 2024
BRIEF published on 04/11/2025 at 10:35, 1 year ago Eckert & Ziegler Proposes €0.50 Dividend for FY 2024 Annual General Meeting Dividend Eckert & Ziegler Financial Year 2024 TecDax
PRESS RELEASE published on 04/11/2025 at 10:30, 1 year ago Eckert & Ziegler Proposes Dividend of € 0.50 for FY 2024 Eckert & Ziegler SE proposes dividend of €0.50 per share for FY 2024. The Annual General Meeting to be held on June 18, 2025 in Berlin Annual General Meeting Shareholders Dividend Eckert & Ziegler SE FY 2024
BRIEF published on 04/10/2025 at 15:05, 1 year ago Eckert & Ziegler : Le consul américain visite l'usine radiopharmaceutique de Braunschweig Traitement Du Cancer Produits Radiopharmaceutiques Lutécium-177 Visite Du Consul Américain Investissement D'expansion
BRIEF published on 04/10/2025 at 15:05, 1 year ago Eckert & Ziegler: US Consul Visits Braunschweig Radiopharmaceutical Facility Cancer Treatment Radiopharmaceuticals Lutetium-177 US Consul Visit Expansion Investment
PRESS RELEASE published on 04/10/2025 at 15:00, 1 year ago Eckert & Ziegler: US Consul Visits Radiopharmaceutical Production in Braunschweig US Consul General Jason Chue visits Eckert & Ziegler's radiopharmaceutical production site in Braunschweig, witnessing the production of cancer diagnostics and therapy solutions Eckert & Ziegler Cancer Therapy Radiopharmaceuticals Lutetium-177 Transatlantic Cooperation
Published on 05/07/2026 at 09:05, 13 minutes ago Nano One Appoints Jason Zandberg as Director of Capital Markets
Published on 05/07/2026 at 05:40, 3 hours 38 minutes ago New Horizon Aircraft Ltd. Announces Pricing of $20 Million Offering of Common Shares
Published on 05/07/2026 at 02:00, 7 hours 18 minutes ago Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 9 hours 48 minutes ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 10 hours 13 minutes ago Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/07/2026 at 09:05, 13 minutes ago MSI IPC Launches Quad-Display MS-C936 Slim Box PC and High-Connectivity MS-CF27 SBC for Industrial Edge Computing
Published on 05/07/2026 at 09:05, 13 minutes ago ARBOR Technology Unveils ARES-2100 Series for Next-Generation Edge AI with Intel Core Series 3 Processors
Published on 05/07/2026 at 09:01, 17 minutes ago The harsh reality for German graduates: four months to find an entry-level job
Published on 05/07/2026 at 09:00, 17 minutes ago Original-Research: ZEAL Network SE (von NuWays AG): BUY
Published on 05/07/2026 at 07:43, 1 hour 35 minutes ago ENGIE - Information Financière 1er trimestre 2026
Published on 05/06/2026 at 18:00, 15 hours 18 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 15 hours 18 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 15 hours 18 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
